DOI QR코드

DOI QR Code

Antibacterial activity of isolated bacteria against Propionibacterium acnes causing acne vulgaris

여드름을 유발하는 Propionibacterium acnes에 대한 분리 세균들의 항균활성

  • Lee, Da-Sol (Department of Biological Sciences, Kangwon National University) ;
  • Song, Hong-Gyu (Department of Biological Sciences, Kangwon National University)
  • Received : 2018.07.17
  • Accepted : 2018.08.29
  • Published : 2018.09.30

Abstract

This study was carried out to evaluate antimicrobial activity of isolated bacteria from various soils against two strains of Propionibacterium acnes causing acne vulgaris. Among several hundreds of bacterial strains, Paenibacillus elgii DS381, Paenibacillus elgii DS1515, Burkholderia gladioli DS518, and Streptomyces lienomycini DS620 showed high antimicrobial activities against the strains of P. acnes. All isolated bacteria showed 15.5 to 34.3 mm inhibition zone diameter in an agar well diffusion test, and especially DS620 showed the highest inhibition zone diameters (28.3~34.3 mm). Antibacterial substances were expected as lipopeptide (pelgipeptin and paenipeptin) from strains DS381 and DS1515, protease from DS518, and anthracycline antibiotic (daunomycinone) from DS620, and all these showed very low minimum inhibitory concentration [DS381 and DS1515 (0.078 mg/ml), DS518 (0.312 mg/ml), DS620 (0.000078 mg/ml)] against P. acnes. These antibacterial substances could completely kill P. acnes within 24 h in a time-kill assay. These results suggest that antibacterial substances produced by these bacteria may be utilized as useful antimicrobial agent against P. acnes and treatment medicine for acne vulgaris.

본 연구는 여드름을 유발하는 세균인 Propionibacterium acnes에 대해 다양한 토양에서 분리된 세균 균주들의 항균효과를 조사하기 위해 수행되었다. 수백 개의 분리 세균균주 중 Paenibacillus elgii DS381과 Paenibacillus elgii DS1515, Burkhoderia gladioli DS518, Streptomyces lienomycini DS620는 2가지 균주의 P. acnes에 대해 높은 항균활성을 나타내었다. 이 분리균주들은 agar well diffusion test에서 15.5~34.3 mm 직경의 저해대를 형성하였으며, 특히 DS620는 가장 큰 저해대 직경(28.3~34.3 mm)을 나타내었다. 분리 균주가 생성하는 항균 물질은 DS381과 DS1515 균주의 경우lipopeptide (pelgipeptin, paenipeptin), DS518은 protease, 그리고 DS620은 anthracycline 인 것으로 추정되며, 이들 모두 P. acnes에 대해매우낮은 최소저해농도를 나타내었다[DS381와 DS1515 (0.078 mg/ml), DS518 (0.312 mg/ml), DS620 (0.000078 mg/ml)]. P. acnes를 대상으로 한 time-kill assay에서는 네 균주의 항균물질이 모두 24시간 이내에 P. acnes를 완전히 사멸시켰다. 이 결과는 네 가지 항균활성 균주들이 분비하는 항균물질들이 여드름을 유발하는 P. acnes에 대하여 효율적인 치료 소재로 사용될 수 있는 가능성을 보여준다.

Keywords

References

  1. Al-Ani I, Zimmermann S, Reichlinga J, and Wink M. 2015. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi drug resistant microbial pathogens. Phytomedicine 22, 245-255. https://doi.org/10.1016/j.phymed.2014.11.019
  2. Ansari A, Aman A, Siddiqui NN, Iqbal S, and Qader SA. 2012. Bacteriocin (BAC-IB17): Screening, isolation and production from Bacillus subtilis KIBGE IB-17. Pak. J. Pharma. Sci. 25, 195-201.
  3. Arihara K, Ogihara S, Mukai T, ltoh M, and Kondo Y. 1996. Salivacin 140, a novel bacteriocin from Lactobacillus salrivarius subsp. salicinius TI 40 active against pathogenic bacteria. Lett. Appl. Microbiol. 22, 420-424. https://doi.org/10.1111/j.1472-765X.1996.tb01194.x
  4. Choi JS, Bae HJ, Kim SJ, and Choi IS. 2013. In vitro antibacterial and anti-inflammatory properties of seaweed extracts against acne inducing bacteria, Propionibacterium acnes. J. Environ. Biol. 32, 313-318.
  5. Chomnawang MT, Surassmo S, Nukoolkarn VS, and Gritsanapan W. 2005. Antimicrobial effects of Thai medicinal plants against acne-inducing bacteria. J. Ethnopharmacol. 101, 330-333. https://doi.org/10.1016/j.jep.2005.04.038
  6. Chu LL, Pandey RP, Shin JY, Jung HJ, and Sohng JK. 2016. Synthetic analog of anticancer drug daunorubicin from daunorubicinone using one-pot enzymatic UDP-recyclingglycosylation. J. Mol. Catal. B Enz. 124, 1-10. https://doi.org/10.1016/j.molcatb.2015.11.020
  7. Desbois AP and Lawlor KC. 2013. Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus. Marine Drugs 11, 4544-4557. https://doi.org/10.3390/md11114544
  8. Fomichova EV, Fedorova GB, Porapova NP, and Katrukha GS. 1992. Isolation and identification of new anthracycline antibiotics, rubomycins F and H. J. Antibiot. 45, 1185-1186. https://doi.org/10.7164/antibiotics.45.1185
  9. Gal SW, Park KH, and Park SS. 2009. Anti-pimple cosmetic resource of culture broth of Paecilomyces japonica mycelium which was incubated with mulberry leaf powder and inhibited the growth of Propionibacterium acnes. Korea Patent KR 1009555630000.
  10. Ghorbel B, Sellami-Kamoun A, and Nasri M. 2003. Stability studies of protease from Bacillus cereus BG1. Enz. Microb. Technol. 32, 513-518. https://doi.org/10.1016/S0141-0229(03)00004-8
  11. Huang E, Yang X, Zhang L, Moon SH, and Yousef AE. 2017. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity. FEMS Microbiol. Lett. 364, 1-6.
  12. Jayaraman P, Sakharkar MK, Lim CS, Tang T, and Sakharkar KR. 2010. Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int. J. Biol. Sci. 6, 556-568.
  13. Jiang J, Shi B, Zhu D, Cai Q, Chen Y, Li J, Qi K, and Zhang M. 2012. Characterization of a novel bacteriocin produced by Lactobacillus sakei LSJ618 isolated from traditional Chinese fermented radish. Food Control 23, 338-344. https://doi.org/10.1016/j.foodcont.2011.07.027
  14. Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, Han YW, Kang H, Kim HO, Rhee JH, Chung MJ, et al. 2009. Antimicrobial activity of enterocims from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J. Microbiol. 47, 101-109. https://doi.org/10.1007/s12275-008-0179-y
  15. Kim TW, Kim SM, Hwang YM, Kim C, Lee DW, Jun LJ, Jeong JB, Kim YO, Nam BH, and Lee KJ. 2018. Determination of mass culture method of marine-derived microorganism, Bacillus sp. 2-4 (KCCMI 11107P) with antimicrobial acitivity. J. Fish. Mar. Sci. Educ. 30, 123-131.
  16. Lim YH, Kim IH, and Seo JJ. 2007. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. J. Microbiol. 45, 473-477.
  17. Luangnarumitchai S, Lamlertthon S, and Tiyaboonchai W. 2007. Antimicrobial activity of essential oils against five strains of Propionibacterium acnes. Mahidol Univ. J. Pharma. Sci. 34, 60-64.
  18. Murugan G and Rengaswamy P. 2011. Isolation, screening and production of biosurfactant by Pseudomonas sp. isolated from mangrove forest soil using coconut oil cake as substrate. J. Basic Appl. Biol. 5, 251-257.
  19. Nagarajkumar M, Bhaskaran R, and Velazhahan R. 2004. Involvement of secondary metabolites and extracellular lytic enzymes produced by Pseudomonas fluorescens in inhibition of Rhizoctonia solani, the rice sheath blight pathogen. Microbiol. Res. 159, 73-81. https://doi.org/10.1016/j.micres.2004.01.005
  20. Niyomkam P, Kaewbumrung S, Kaewnpparat S, and Panichayupakaranant P. 2010. Antibacterial activity of Thai herbal extracts on acne involved microorganism. Pharma. Biol. 48, 375-380. https://doi.org/10.3109/13880200903150443
  21. Nord CE and Oprica C. 2006. Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects. Anaerobe 12, 207-210. https://doi.org/10.1016/j.anaerobe.2006.08.001
  22. Nostro A, Germano MP, D'Angelo V, Marino A, and Cannatelli MA. 2000. Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity. Lett. Appl. Microbiol. 30, 379-384. https://doi.org/10.1046/j.1472-765x.2000.00731.x
  23. Oh SJ, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park SS, and Kim YJ. 2006. Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria. Food Chem. Toxicol. 44, 1184-1190. https://doi.org/10.1016/j.fct.2005.08.008
  24. Ross JI, Eady EA, and Cove JH. 1997. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob. Agents 41, 1162-1165. https://doi.org/10.1128/AAC.41.5.1162
  25. Sharma D and Saharan BS. 2014. Simultaneous production of biosurfactants and bacteriocins by probiotic Lactobacillus casei MRTL3. Int. J. Microbiol. 2014, 1-7.
  26. Singh LS, Sharma H, and Talukdar NC. 2014. Production of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from phoomdi in Loktak Lake of Manipur, India. BMC Microbiol. 14, 278. https://doi.org/10.1186/s12866-014-0278-3
  27. Sopirala MM, Mangino JE, Gebreyes WA, Biller B, Bannerman T, Balada-Llasat JM, and Pancholi P. 2010. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 4678-4683. https://doi.org/10.1128/AAC.00497-10
  28. Steenbergen JN, Alder J, Thorne GM, and Tally FP. 2005. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 55, 283-288. https://doi.org/10.1093/jac/dkh546
  29. Vowels BR, Yang S, and Leyden JJ. 1995. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect. Immun. 63, 3158-3165.
  30. Webster GF. 2002. Acne vulgaris. British Med. J. 325, 475-479. https://doi.org/10.1136/bmj.325.7362.475
  31. Zu Y, Yu H, Liang L, Fu Y, Efferth T, Liu X, and Wu N. 2010. Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells. Molecules 15, 3200-3210. https://doi.org/10.3390/molecules15053200